217 related articles for article (PubMed ID: 33878034)
21. Altered expression of fucosylation pathway genes is associated with poor prognosis and tumor metastasis in non‑small cell lung cancer.
Park S; Lim JM; Chun JN; Lee S; Kim TM; Kim DW; Kim SY; Bae DJ; Bae SM; So I; Kim HG; Choi JY; Jeon JH
Int J Oncol; 2020 Feb; 56(2):559-567. PubMed ID: 31894325
[TBL] [Abstract][Full Text] [Related]
22. Fucosylation in Urological Cancers.
Fujita K; Hatano K; Hashimoto M; Tomiyama E; Miyoshi E; Nonomura N; Uemura H
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948129
[TBL] [Abstract][Full Text] [Related]
23. Fucosylation of LAMP-1 and LAMP-2 by FUT1 correlates with lysosomal positioning and autophagic flux of breast cancer cells.
Tan KP; Ho MY; Cho HC; Yu J; Hung JT; Yu AL
Cell Death Dis; 2016 Aug; 7(8):e2347. PubMed ID: 27560716
[TBL] [Abstract][Full Text] [Related]
24. SOX9 enhances sorafenib resistance through upregulating ABCG2 expression in hepatocellular carcinoma.
Wang M; Wang Z; Zhi X; Ding W; Xiong J; Tao T; Yang Y; Zhang H; Zi X; Zhou W; Huang G
Biomed Pharmacother; 2020 Sep; 129():110315. PubMed ID: 32554246
[TBL] [Abstract][Full Text] [Related]
25. USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation.
Ling S; Shan Q; Zhan Q; Ye Q; Liu P; Xu S; He X; Ma J; Xiang J; Jiang G; Wen X; Feng Z; Wu Y; Feng T; Xu L; Chen K; Zhang X; Wei R; Zhang C; Cen B; Xie H; Song P; Liu J; Zheng S; Xu X
Gut; 2020 Jul; 69(7):1322-1334. PubMed ID: 31776228
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
[TBL] [Abstract][Full Text] [Related]
27. LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3.
Shu G; Su H; Wang Z; Lai S; Wang Y; Liu X; Dai L; Bi Y; Chen W; Huang W; Zhou Z; He S; Dai H; Tang B
J Exp Clin Cancer Res; 2021 Jan; 40(1):45. PubMed ID: 33499874
[TBL] [Abstract][Full Text] [Related]
28. Caveolin-1 upregulates Fut8 expression by activating the Wnt/β-catenin pathway to enhance HCC cell proliferative and invasive ability.
Zhang C; Wu Q; Huang H; Chen X; Huang T; Li W; Zhang J; Liu Y
Cell Biol Int; 2020 Nov; 44(11):2202-2212. PubMed ID: 32710651
[TBL] [Abstract][Full Text] [Related]
29. MELK is an oncogenic kinase essential for early hepatocellular carcinoma recurrence.
Xia H; Kong SN; Chen J; Shi M; Sekar K; Seshachalam VP; Rajasekaran M; Goh BKP; Ooi LL; Hui KM
Cancer Lett; 2016 Dec; 383(1):85-93. PubMed ID: 27693640
[TBL] [Abstract][Full Text] [Related]
30. Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma.
Nio K; Yamashita T; Okada H; Kondo M; Hayashi T; Hara Y; Nomura Y; Zeng SS; Yoshida M; Hayashi T; Sunagozaka H; Oishi N; Honda M; Kaneko S
J Hepatol; 2015 Nov; 63(5):1164-72. PubMed ID: 26095183
[TBL] [Abstract][Full Text] [Related]
31. Site-specific glycoproteomic analysis revealing increased core-fucosylation on FOLR1 enhances folate uptake capacity of HCC cells to promote EMT.
Jia L; Li J; Li P; Liu D; Li J; Shen J; Zhu B; Ma C; Zhao T; Lan R; Dang L; Li W; Sun S
Theranostics; 2021; 11(14):6905-6921. PubMed ID: 34093861
[No Abstract] [Full Text] [Related]
32. Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies.
Liu YC; Yeh CT; Lin KH
Cells; 2020 May; 9(6):. PubMed ID: 32466488
[TBL] [Abstract][Full Text] [Related]
33. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
Hirata H; Sugimachi K; Komatsu H; Ueda M; Masuda T; Uchi R; Sakimura S; Nambara S; Saito T; Shinden Y; Iguchi T; Eguchi H; Ito S; Terashima K; Sakamoto K; Hirakawa M; Honda H; Mimori K
Cancer Res; 2016 Jun; 76(11):3265-76. PubMed ID: 27197151
[TBL] [Abstract][Full Text] [Related]
34. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.
Zhao X; Zheng F; Li Y; Hao J; Tang Z; Tian C; Yang Q; Zhu T; Diao C; Zhang C; Chen M; Hu S; Guo P; Zhang L; Liao Y; Yu W; Chen M; Zou L; Guo W; Deng W
Redox Biol; 2019 Jan; 20():427-441. PubMed ID: 30419422
[TBL] [Abstract][Full Text] [Related]
35. ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation.
Lin Q; Wu Z; Yue X; Yu X; Wang Z; Song X; Xu L; He Y; Ge Y; Tan S; Wang T; Song H; Yuan D; Gong Y; Gao L; Liang X; Ma C
EBioMedicine; 2020 Mar; 53():102676. PubMed ID: 32114388
[TBL] [Abstract][Full Text] [Related]
36. Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway.
Lo RC; Leung CO; Chan KK; Ho DW; Wong CM; Lee TK; Ng IO
Cell Death Differ; 2018 Aug; 25(8):1426-1441. PubMed ID: 29445127
[TBL] [Abstract][Full Text] [Related]
37. Intrinsic hepatocyte dedifferentiation is accompanied by upregulation of mesenchymal markers, protein sialylation and core alpha 1,6 linked fucosylation.
Mehta A; Comunale MA; Rawat S; Casciano JC; Lamontagne J; Herrera H; Ramanathan A; Betesh L; Wang M; Norton P; Steel LF; Bouchard MJ
Sci Rep; 2016 Jun; 6():27965. PubMed ID: 27328854
[TBL] [Abstract][Full Text] [Related]
38. Cancer-associated fibroblasts promote the stemness of CD24
Li Y; Wang R; Xiong S; Wang X; Zhao Z; Bai S; Wang Y; Zhao Y; Cheng B
J Mol Med (Berl); 2019 Feb; 97(2):243-255. PubMed ID: 30564864
[TBL] [Abstract][Full Text] [Related]
39. MiR-30e-3p Influences Tumor Phenotype through
Gramantieri L; Pollutri D; Gagliardi M; Giovannini C; Quarta S; Ferracin M; Casadei-Gardini A; Callegari E; De Carolis S; Marinelli S; Benevento F; Vasuri F; Ravaioli M; Cescon M; Piscaglia F; Negrini M; Bolondi L; Fornari F
Cancer Res; 2020 Apr; 80(8):1720-1734. PubMed ID: 32015093
[TBL] [Abstract][Full Text] [Related]
40. c-Jun transcriptionally regulates alpha 1, 2-fucosyltransferase 1 (FUT1) in ovarian cancer.
Gao N; Liu J; Liu D; Hao Y; Yan L; Ma Y; Zhuang H; Hu Z; Gao J; Yang Z; Shi H; Lin B
Biochimie; 2014 Dec; 107 Pt B():286-92. PubMed ID: 25239830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
